Multiply Labs
San Francisco, United States
Industrial Arms & Cobots · Founded 2016 · Series B
Multiply Labs builds robotic systems that automate existing biomanufacturing instruments for cell and gene therapies and other advanced biologics. Its Robotic Cluster packs four Universal Robots cobots and modular instrument towers into a closed, GMP-compliant environment without requiring process transfer. The platform's Process Creator app lets scientists build and modify manufacturing protocols with no code, while built-in software records every step and sensor reading in 21 CFR Part 11 compliant electronic records. The company says its approach can raise throughput by up to 100x and cut cost per dose by 74%. Customers and partners include AstraZeneca, Legend Biotech and Kyverna Therapeutics. Founded in 2016 and based in San Francisco, it closed a $75 million Series B in October 2026.
Visit website- Based in
- San Francisco, United States
- Founded
- 2016
- Builds
- Industrial Arms & Cobots, Robotics Development Software & Tools
- Industries
- Healthcare, Manufacturing
- Stage
- Series B
- Team
- 50 to 100 people
- Funding raised
- $116M
- Open roles
- 9